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Abstract
Introduction: Mesenchymal stem cells (MSCs) play a central role in mediating endogenous repair of cell and tissue
damage. Biologic aging is a universal process that results in changes at the cellular and molecular levels. In the
present study, the role of microRNA (miRNA) in age-induced molecular changes in MSCs derived from adipose
tissue (ASCs) and bone marrow (BMSCs) from young and old human donors were investigated by using an
unbiased genome-wide approach.
Methods: Human ASCs and BMSCs from young and old donors were cultured, and total RNA was isolated. The
miRNA fraction was enriched and used to determine the expression profile of miRNA in young and old donor
MSCs. Based on miRNA expression, differences in donor MSCs were further investigated by using differentiation
assays, Western blot, immunocytochemistry, and bioinformatics.
Results: Biologic aging demonstrated reduced osteogenic and adipogenic potential in ASCs isolated from older
donors, whereas cell size, complexity, and cell-surface markers remained intact with aging. Analysis of miRNA
profiles revealed that small subsets of active miRNAs changed secondary to aging. Evaluation of miRNA showed
significantly decreased levels of gene expression of inhibitory kappa B kinase (IB), interleukin-1a, inducible nitric
oxide synthase (iNOS), mitogen-activated protein kinase/p38, ERK1/2, c-fos, and c-jun in MSCs from older donors by
both bioinformatics and Western blot analysis. Nuclear factor kappa B (NF-B), myc, and interleukin-4 receptor
mRNA levels were significantly elevated in aged cells from both the adipose and bone marrow depots.
Immunocytochemistry showed nuclear localization in young donors, but a cytosolic predominance of
phosphorylated NF-B in ASCs from older donors. Western blot demonstrated significantly elevated levels of NF-B
subunits, p65 and p50, and AKT.
Conclusions: These findings suggest that differential expression of miRNA is an integral component of biologic
aging in MSCs.
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Age-related changes occur in all biologic systems, from
the phenotypic to the molecular level, leading to activa-
tion and deactivation of cellular pathways. Recent stu-
dies suggest that mesenchymal stem cells (MSCs) are
subject to changes that accompany biologic aging [1-3].
MSCs, also known as mesenchymal stromal cells, are a
multipotent, heterogeneous population of cells that pos-
sess the ability to differentiate along a variety of cell
lineages. MSCs have been isolated from numerous tissue
sources, including the bone marrow (BMSCs) and adi-
pose tissue (ASCs), and have been shown to retain the
ability to differentiate into numerous terminally differen-
tiated cell types, including bone, cartilage, fat, muscle,
and skin [4-6]. Studies also have investigated the role of
MSCs as therapeutic agents in many disease states [4,7].
It has been suggested that populations of MSCs are
depleted with age and that reduction in MSC pools con-
tributes to human aging and the onset of age-related
disease processes [8,9].
Biologic aging can affect not only the absolute num-
bers of MSCs, but also the expression profile of these
cells [9-11]. Indeed, MSCs appear to be as susceptible as
other cells to molecular alterations that result from in
vivo biologic aging [2,3,12]. It has been suggested that
MSCs isolated from older donors have an overall decline
in differentiation potential or may show a greater pro-
pensity toward adipogenesis than toward other cell fates;
however, most of these studies focused solely on BMSCs
[1,2,13]. Other reports allude to a more complex pattern
of events, especially with regard to the adipogenic
potential of MSCs and aging [14]. However, the changes
exhibited by MSCs due to aging have not been fully
delineated. Moreover, the effect of aging on the thera-
peutic potential of MSCs for regenerative medicine
remains to be fully elucidated. It has been suggested
that microRNAs (miRNAs) play an integral role in the
regulation of aging and subsequent changes associated
with the aging process [15-18]. Specifically, miRNAs,
which are small 19- to 27-nucleotide (nt) RNA frag-
ments, function in the translational regulation of gene
expression. They are members of a large class of small
noncoding RNAs. Degradation and repression of target
mRNA transcripts are the primary mechanisms whereby
miRNAs regulate gene expression and influence cellular
processes and signaling mechanisms [19,20]. It has been
estimated that approximately two thirds of the whole
mammalian genome may be influenced by translational
regulation of gene expression by miRNA activity [21].
Indeed, miRNAs appear to be integral regulators of gene
expression, influencing processes that include aging,
apoptosis, cancer, and inflammation [15,22,23].
Recent studies have investigated the role of miRNAs
in MSCs as they progress from undifferentiated states to
differentiated end-cell fates, in a variety of species
[24,25]. No investigations to date, however, have delved
into the effects of biologic age-induced miRNA changes
on MSCs. Given the potential of MSCs as cellular thera-
peutic agents, it is imperative to gain a full understand-
ing of the effects of biologic aging on MSC properties,
as well as the potential benefits and risks of using older
or younger donor MSCs as treatment modalities.
In the current study, the alterations in the miRNA
profiles of MSCs isolated from old and young donors
were investigated, and significant downstream altera-
tions that may be manifested secondary to biologic
aging have been identified.
Materials and methods
Materials
Cell-culture materials, including Hank’s buffered saline
solution (HBSS), a-modified Eagle’sm e d i u m( a-MEM),
L-glutamine, penicillin/streptomycin, phosphate-buffered
saline (PBS), and trypsin/EDTA were obtained from
Invitrogen (Carlsbad, CA). Fetal bovine serum (FBS) was
purchased from Atlanta Biological (Atlanta, GA). All
reagents for miRNA and mRNA arrays were obtained
from SABiosciences (Frederick, MD), including whole
human genome miRNA array, signal-transduction path-
way finder arrays, and RT
2 First Strand Kits. Protease
and phosphatase inhibitor cocktails, RIPA buffer, and
BCA protein quantification kits were ordered from
Thermo Scientific (Rockford, IL). Western blot reagents
were obtained from Invitrogen; these included loading
buffer, reducing agent, 4% to 12% Bis-Tris SDS-PAGE
gels, iblot nitrocellulose membrane and blotting compo-
nents, and chemiluminescence HRP developer kits. The
chemiluminescence blocker was acquired from Millipore
(Billerica, MA). All antibodies, both primary and sec-
ondary, were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA). All other chemicals used were mole-
cular biology reagent grade.
Mesenchymal stem cell isolation and expansion
ASCs and BMSCs were isolated and expanded as pre-
viously reported [26]. In brief, ASCs were isolated from
subcutaneous white adipose tissue. BMSCs were
obtained from the iliac crest or marrow discarded dur-
ing orthopedic procedures [2,26]. In brief, BMSCs were
separated over a Ficoll gradient by centrifugation for 30
minutes at 1,800 g. Similarly, ASCs were isolated from
subcutaneous white adipose tissue, after which the adi-
pose tissue was digested with 0.075% collagenase for 30
minutes at 37°C to isolate ASCs. Subsequently, all cells
were washed in HBSS or PBS, and then centrifuged at
300 g (ASC) or 1,000 g (BMSC) for 10 minutes. The pel-
leted nucleated cells were cultured overnight in a humi-
dified atmosphere at 37°C with 5% CO2 in complete
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a-MEM, 20% FBS, 1% L-glutamine, and 1% penicillin/
streptomycin or stromal medium (SM) for ASCs
(DMEM/F12, 10% FBS, 1% penicillin/streptomycin/
amphotericin). The CCM was replaced every third day
until the cells reached 70% to 80% confluence. All cells
u s e dw e r eb e t w e e np a s s a g e s3a n d5a n di d e n t i f i e da s
young donors (younger than 50 years) or old donors
(older than 50 years). Young donors of ASCs were an
average age of 31.5 ± 10.4 years, whereas BMSCs were
31.5 ± 8.7 years; old donors of ASCs were an average
age of 63 ± 6.0 years, and old donors of BMSCs were an
average age of 56.3 ± 5.0 years. Investigators were
blinded to donor information about the ASCs and
BMSCs; however, donor age, race, and other selected
demographics were obtained. All donor groups had sig-
nificant differences in age, but no other significant
demographic differences, including BMI. All cells were
isolated after review and approval by the institutional
review board (IRB) of Tulane University School of Med-
icine, Pennington Biomedical Research Center, or Brig-
ham and Women’s Hospital, with informed patient
consent.
Flow cytometry
Flow cytometry was performed as previously described
[27]. After MSCs were 70% confluent, CCM was aspi-
rated, and cells were washed twice with PBS. Cells were
harvested with trypsin, and resuspended in PBS for ana-
lysis. Cells were assessed for size by using forward and
side light-scatter measurements. In addition, all cells
were characterized by examination for cell-surface mar-
kers by using an extensive panel of antibodies developed
b yo u rC e n t e ro v e rt h ep a s ts e v e r a l - y e a r sp e r i o d[ 2 8 ] .
Both BMSCs and ASCs expressed known MSC markers
including CD29, CD44, CD90, CD105, CD166, and HLA
class I. Both cell types were negative for lymphohemato-
poietic lineage markers, such as CD3, CD34, CD45,
CD11b, and CD19.
Differentiation assay
The ability of MSCs to differentiate along osteogenic
and adipogenic lineages was adapted from our pre-
viously described methods [29,30]. In brief, cells were
plated in 24-well plates and cultured in CCM until they
attained 70% confluence. Culture medium was then
aspirated and replaced with differentiation-specific med-
ium. Osteogenic differentiation was assessed by staining
for bone mineralization with Alizarin Red. Assessment
of lipid inclusions, which indicate differentiation to adi-
pocytes, was done by staining with Oil Red O solution,
followed by microscopic examination on a Nikon Eclipse
TE200 microscope (Nikon Instruments, Melville, NY).
Differentiation was quantified as previously described
[31]. In brief, after cells were stained, they were
destained by using 10% cetylpyridinium chloride for
Alzarian Red and isopropyl alcohol for Oil Red O. Col-
lected samples were then analyzed by using a microplate
reader at 580 nm to assess the optical density (OD) of
the collected samples. Sample OD values were then nor-
malized to protein concentrations of the differentiated
cells.
miRNA profiling arrays of MSCs
The microRNA profiling was performed by using the
SABiosciences quantitative polymerase chain reaction
(qPCR) array platform according to the protocols of the
SABiosciences service core. In total, 16 donors, compris-
ing four young and four old donors of ASCs and
BMSCs, respectively, were analyzed with the whole
human genome miRNA qPCR array. Samples of ASCs
and BMSCs were pelleted and quantified to contain
approximately 1 × 10
7 cells per donor. Cell pellets were
flash frozen with liquid nitrogen and sent to the SABios-
ciences service core (Frederick, MD) for total RNA iso-
lation, miRNA enrichment, qPCR-based array, and data
report. The miRNA profile was analyzed for hierarchic
clustering of miRNA by using Genesis to generate heat-
maps (Genesis, Austria) [32]. Genesis was also used to
cluster donor profiles to identify individual donor
variability.
Target generation from miRNA data
In addition to targets for miRNA action that have been
validated in reported studies, potential targets for
miRNA action were predicted by using putative targets
generated from TargetScan Human V5.1. TargetScan
Human predicts putative targets based on factors that
include sequence homology, predicted biologic function,
and verified targets. The predicted targets were ranked
in order of conserved sequences and the prospect of
regulation of gene expression via miRNA activity by
using a context score, and previous studies have shown
that context scores less than -0.3 are commonly consid-
ered biologically relevant [33]. The predicted gene tar-
gets were analyzed with Ingenuity Pathways Assessment
(IPA) and the Ingenuity Knowledgebase (Version 8.7,
Ingenuity Systems, Redwood City, CA).
Bioinformatics analysis of generated miRNA targets
Targets generated by TargetScan were entered into IPA
to delineate further the interactions and functions of
miRNA on mRNA levels and the protein expression.
IPA also generated lists of focus molecules, which were
defined by direct and indirect molecules. Direct mole-
cules were those input directly into IPA, such as the tar-
gets from TargetScan. Indirect molecules were those
that have been described in previous studies, are
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part of the Ingenuity Knowledgebase. IPA was used to
gain insight into the interacting networks of the focus
molecules, canonic pathway involvement, biologic func-
tions, and cellular processes influenced by miRNA
actions. Canonic pathways are those pathways in which
miRNA may play integral roles in regulation. IPA analy-
sis generates these canonic pathways based on the inte-
gration of inputted mRNA targets that were generated
from significantly changed miRNA. Biologic functions
are generated by IPA analysis investigating which phy-
siological and pathological functions may be influenced
by the inputted targets. Both the canonic pathways and
biologic functions are then evaluated for statistical
significance.
mRNA arrays of MSCs
Signal-transduction qPCR-based array was obtained
from SABiosciences and was performed according to
the manufacturer’s instructions. In brief, total RNA iso-
lated for the miRNA arrays was obtained from two ASC
samples based on clustering of the miRNA profile of
donors. Representative samples from young and old
donors were selected for analysis. Total RNA samples
(500 ng) were processed for cDNA synthesis by using a
RT
2 First Strand Kit according to the manufacturer’s
protocol. The Signal Transduction Pathway Finder array
from SABiosciences was performed on a Bio-Rad CFX96
real-time PCR machine (Bio-Rad, Hercules, CA), accord-
ing to the manufacturer’s instructions. Data from the
array were analyzed with the SABiosciences software by
observed Ct values and determining the relative fold
change as compared with housekeeping genes. House-
keeping genes used as internal controls included b2-
microglobulin, hypoxanthine phosphoribosyltransferase
1, ribosomal protein L13a, glyceraldehyde-3-phosphate
dehydrogenase, and b-actin.
Subcellular localization of NF-B subunits by
immunocytochemistry
Representative ASCs from old and young donors were
selected based on hierarchic clustering of donors from
miRNA analysis. Cells were plated at a density of 1 ×
10
4 cells per 0.4 cm
2. The next day, cells were fixed for
15 minutes at room temperature, washed, permeabilized
for 5 minutes at room temperature, and washed again.
Cells were incubated overnight at 4°C with a 1:200 dilu-
t i o no fp 5 0a n dp 6 5s u b u n i t so fN F - B, followed by 1
hour at room temperature with a 1:1,000 dilution of a
goat anti-rabbit FITC secondary antibody. Slides were
counterstained with DAPI, photographed with a Leica
DMRXA2 microscope, and rendered with Slidebook
software (Denver, CO).
Cell lysate and protein isolation
A S C sw e r eg r o w ni n1 5 - c m
2 dishes to 70% confluence
at 37°C, as described earlier. Cells were washed twice
with PBS and harvested with trypsin/EDTA. Cells were
centrifuged, collected, flash frozen in liquid nitrogen,
and stored at -80°C. Cell pellets were lysed in RIPA buf-
fer (reference for RIPA buffer) containing protease and
phosphatase inhibitor cocktails. Cell lysate was incu-
bated on ice for 15 minutes with intermittent agitation,
and clarified by centrifuging at 14,000 g for 15 minutes
at 4°C. The supernatant was collected, and the protein
concentration of samples was assessed by using a BCA
kit and microplate reader (Optica). Protein samples
were stored at -80°C until assayed.
Western blot analysis
Aliquots of 10 μg of total cellular protein from ASCs
from old and young donor sample buffered with redu-
cing agent were reduced, boiled, and placed on ice. Bis-
Tris 4% to 12% SDS-PAGE gels were used to separate
proteins of interest, which were transferred to a nitro-
cellulose membrane. The membranes were developed
with chemiluminescence HRP developer according to
the manufacturer’s directions, and then immediately
imaged by using the Image Quant LAS 4000 imager (GE
Healthcare Life Sciences, Piscataway, NJ). Analysis and
densitometry were performed with the Image Quant
software and Image Quant imager.
Statistical analysis
The miRNA data were analyzed for relative fold changes
from Ct values by using the 2
-ΔΔCt method [34]. Statisti-
cal significance was determined by comparisons of rela-
tive fold regulation of older versus younger donors, with
a P value < 0.05 indicating significance. Data for miRNA
were normalized to the average of four small RNA mole-
cules, SNORD48, SNORD47, SNORD44, and RNU6. For
analysis of mRNA data, relative fold changes were deter-
mined from Ct values by using the 2
-ΔΔCt method. Statis-
tical significance was determined by comparison of fold
regulation of older with younger donors, with fold regula-
tion more than equal or less than equal to ± 2, indicating
significance. Additionally, P values were calculated for
the miRNA expression profiles, and a P < 0.05 was used
to identify those miRNAs whose fold changes were sig-
nificant. IPA analysis used the right-tailed Fisher Exact
test to calculate P values, with a P < 0.05 indicating sig-
nificance of association to predicted targets and potential
involvement in canonic pathways, biologic function, and
networks assessment. All other data were analyzed with
Sigma Plot by using a Student test, with P <0 . 0 5i n d i c a t -
ing statistical significance. All data are presented as mean
± standard error of the mean (SEM).
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Characterization of MSCs
ASCs and BMSCs were grown in specific culture media
to determine their ability to differentiate along osteo-
genic and adipogenic lineages. MSCs, collectively both
ASCs and BMSCs, from each age group demonstrated
bone mineralization and neutral lipid accumulation in
the appropriate culture medium and conditions, thus
confirming the multipotent nature of the MSCs (Figure
1a). Quantification of differentiation based on histo-
chemical staining showed significantly less mineraliza-
tion (Alizarin Red) and lipid production (Oil Red O) in
MSCs from older donors (50 years or older) than in
MSCs from younger donors (50 tears or younger) (P <
0.05); these data indicate that the differentiation poten-
tials of MSCs are associated with the biologic age of the
donor (Figure 1b). Specifically, bone mineralization of
cultures of MSCs from younger donors was 1.4-fold that
for MSCs from older donors. Similarly, adipogenesis in
MSCs from younger donors was 2.3-fold that for MSCs
from older donors. Undifferentiated cells were charac-
terized with flow cytometry for the presence of com-
monly identified cell-surface markers for MSCs and
were consistent with the commonly accepted profile. No
discernible differences were found in stromal cell-sur-
face marker profiles between donors based on age and
cell type based on tissue of origin (data not shown).
Assessment of forward versus side light scatter revealed
no significant age-related differences in cell size for
ASCs and BMSCs (Figure 1c).
Changes in the miRNA profiles of ASCs and BMSCs
secondary to biologic aging
The miRNA profiles of ASCs and BMSCs from older
and younger donors were analyzed with the qPCR-based
array for miRNA of the whole human genome (Figure
2). Age-specific analysis showed significant differences
(P < 0.05 compared with internal controls) in 45 miR-
NAs in BMSCs; these constituted approximately 5.86%
of all evaluated human miRNAs (Figure 3a). For ASCs,
significant age-related differences appeared in expression
of 14 of 768 miRNAs, constituting 1.82% of all screened
targets (Figure 3b). For both ASCs and BMSCs, greater
numbers of miRNAs were downregulated in specimens
from older donors than from younger donors (Figure
3c-f). The BMSCs showed that more than 95% of the
significantly changed miRNAs were downregulated with
age. ASCs had more than 85% of significantly changed
miRNA downregulated with age. Specifically, 43 miRNA
and 12 miRNAs in BMSCs and ASCs, respectively, were
downregulated with age. Interestingly, ASCs and BMSCs
each had two unique miRNAs among those screened
that were significantly upregulated in older donors (Fig-
ure 3g, h).
MicroRNA target prediction and bioinformatics
assessments
Lists of predicted genes associated with significant miR-
NAs differentially expressed secondary to age-related
differences within a subset grouping (for example,
downregulated BMSCs in older versus younger donors)
Figure 1 Characterization of age-dependent differences in
adipose stem cells (ASCs) and bone marrow stem cells
(BMSCs). (a) Representative photomicrographs of MSCs show
undifferentiated control cells (left), lipid inclusions with Oil Red O
(middle), and mineralization with Alizarin Red (right) in ASCs from
young (top) and old (bottom) donors. Original magnification of
undifferentiated and mineralized cultures was ×10, and lipid
inclusions were at ×40. (b) Quantification of differentiation
potentials of ASCs from young and old donors shown as OD
normalized to protein for cells cultured in osteoblastogenic and
adipocytogenic conditions. Bars represent mean ± SEM and are
representative of three quantifications. *P < 0.05. (c) A
representative plot from flow cytometry shows forward versus side
light scatter used to assess cell size and heterogeneity of MSCs.
Green plots demonstrate ASCs, and red plots indicate BMSCs. Data
for young donors are on the right, and for old donors, on the left.
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(a) Expression of miRNA in old and young BMSC donors, and mapping of hierarchic clustering of miRNA and heatmap display of miRNA
profiles. (b) Expression of miRNA in old and young ASC donors, and mapping of hierarchic clustering of miRNA and heatmap display of miRNA
profiles. Columns represent individual donor samples, and each row represents individual assayed miRNA. Green represents downregulation of
miRNAs, and red represents upregulation of miRNAs.
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Page 6 of 18Figure 3 Age-dependent changes in miRNA profiles of adipose stem cells (ASCs) and bone marrow stem cells (BMSCs). (a) Statistically
significant up- and downregulated miRNA in BMSCs. (b) Statistically significant up- and downregulated miRNA in ASCs. (c, d) Volcano plot of
miRNA exhibiting P < 0.05 in expression as a result of BMSCs donor age. (e, f) Volcano plot of miRNA exhibiting P < 0.05 in expression as a
result of ASCs donor age. (g) Fold regulation of significant miRNA in old versus young BMSCs donors. (h) Fold regulation of significant miRNA in
old versus young ASCs donors. Upregulated miRNA are denoted in red, downregulated miRNAs are green, and miRNAs not statistically
significant are black. Horizontal blue line represents P-value cutoff (P < 0.05), and vertical grey lines represent fold-change cutoff (more than
twofold).
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was then used to generate canonic pathway involvement,
biologic functions, and network analysis for the pre-
dicted targets. Canonic pathways generated for up- and
downregulated miRNAs in BMSCs from older as com-
pared with younger donors demonstrated the involve-
ment of many pathways (Figure 4a, b). The pathways
associated with the largest age-related decreases in
miRNA levels of BMSCs (P ≤ 0.05) included those
involved in molecular mechanisms of cancer, PTEN sig-
naling, mTOR signaling, and RAN signaling. It would be
predicted that those pathways would have increased
activity because the inhibitory miRNA levels were down-
regulated. Among the canonic pathways associated with
the largest age-related increases in miRNA of older
donor BMSCs were Wnt/b-catenin signaling, tight-junc-
tion signaling, cleavage and polyadenylation of pre-
mRNA, and SAPK/JNK signaling; these observations
suggest decreased activity of those component molecules
in the older BMSCs. Analysis of downregulated miRNAs
in ASCs revealed significant involvement of the canonic
pathways, including molecular mechanisms of cancer,
axonal guidance signaling, ephrin receptor signaling, and
PPARa/RXRa activation (Figure 4c, d). The canonic
pathways associated with the largest age-related
increases in miRNA levels of older donor ASCs included
RAN signaling, AMPK signaling, and cell-cycle regula-
tion; however, none achieved the P-value threshold.
Subsequently, the gene lists of putative targets were ana-
lyzed with IPA software for biologic functions manifested
secondary to age-dependent miRNA expression in MSCs.
For age-related decreased miRNA targets of BMSCs, the
top functions mapped included increased gene expression,
organismal development, and cardiovascular disease (Fig-
ure 5a). For age-related increased miRNA targets in
BMSCs, those with inhibition of biologic functions
included cell morphology, cancer, and diseases of the
reproductive system (Figure 5b). For ASCs, age-related
decreased miRNA targets predict greater involvement of
gastrointestinal disease, geriatric disorders, and inflamma-
tory disease states (Figure 5c). For age-related increased
miRNA targets in ASCs, the biologic functions that would
be inhibited included cellular development, embryonic
development, and gene expression (Figure 5d).
From the data for canonic pathways and biologic func-
tions, IPA assessed networks of focus molecules, which
were then grouped for the generation of networks of
directly and indirectly involved molecules (data not
shown). For age-related decreased miRNA in BMSCs,
the major networks were related to cellular movement,
cell signaling, cell death, and inflammatory diseases (Fig-
ure 6a, b). For age-related increased miRNA in BMSCs,
major network functions involved cellular compromise,
antigen presentation, cellular growth and proliferation,
cell death, and cancer (Figure 6a, b). For age-related
decreased miRNA in ASCs, the major significant net-
works were related to cell signaling, molecular transport,
cell cycle, and gene expression (Figure 7a, b). For age-
related increased miRNA in ASCs, major network func-
tions were related to the cell cycle, cell-to-cell signaling
and interaction, and cellular development (Figure 7a, b).
The focus molecules were mapped by IPA, which gener-
ated networks of interaction between focus molecules
and predicted or commonly associated target molecules.
Major network pathways were created for up- and
downregulated ASCs and BMSCs. Collectively, canonic
pathways generated by IPA and analysis of the focus
molecules networks reveal potential targets that miRNA
differentially expressed in MSCs aging. Comprehensive
evaluation of these major focus molecules from IPA
revealed that miRNAs influencing NF-B, ERK1/2, and
IB were directly involved.
Age-related differences in constitutive mRNA expression
in MSCs secondary to miRNA regulation
Representative ASCs from both age groups were
selected based on microarray data clustering for further
evaluation of the predicted effects of miRNA on consti-
tutive mRNA expression. These representative ASCs
were analyzed by qPCR-based signal-transduction array.
This analysis confirmed that mRNA levels of the MAPK
elements, iNOS, VCAM1, and IKK, as well as other NF-
B-pathway-related molecules were downregulated in
ASCs from older donors compared with those from
younger donors (Figure 8a through 8c). In contrast,
mRNA for NF-B and non-classically activated NF-B
targets, such as IL-4 receptor and myc, were significantly
elevated. Other significantly upregulated mRNA in ASCs
from older donors included WNT/b-catenin pathway
constituents. Analysis ofm R N Al e v e l sb yu s i n gI P A
showed similar canonic pathways and biologic functions
as predicted from the miRNA data (Figure 7d through
7e). Analysis of focus molecules showed that major
components of the MAPK/ERK pathway were downre-
gulated in older donors and predicted depressed expres-
sion of related molecules. Furthermore, although the
a r r a ys h o w e de l e v a t e dl e v e l so fN F - Bm R N At h a tI P A
predicted based on the array data, other traditionally
associated components of the inflammatory cascade
were downregulated (Figure 8f through 8i). The excep-
tion to this was tumor necrosis factor-a (TNF-a), which
IPA predicted would be increased due to a downregula-
tion of miRNAs that act on it. Evaluation of mRNA
levels of TNF-a showed increased levels; the fold differ-
ence compared with younger donors, however, was not
significant. IPA and the Ingenuity Knowledgebase
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Page 8 of 18Figure 4 Canonic pathway of predicted gene expression influenced by miRNA in adipose stem cells (ASCs) and bone marrow stem
cells (BMSCs). Canonic pathways derived from predicted putative targets of miRNA action on gene expression by using Ingenuity Pathways
Assessment (IPA) analysis of MSCs from old versus young donors. (a) Downregulated miRNA in BMSCs from old compared with young donors.
(b) Upregulated miRNA in BMSCs from old, compared with young donors. (c) Downregulated miRNA in ASCs from old, compared with young
donors. (d) Upregulated miRNA in ASCs from old, compared with young donors. Yellow line represents P-value cutoff (P < 0.05), and yellow dots
represent ratio of projected involvement of targets to actual inputted involvement. Height of bars is determined by projected involvement of
particular pathway.
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Page 9 of 18Figure 5 Predicted biologic functions influenced by miRNA expression in adipose stem cells (ASCs) and bone marrow stem cells
(BMSCs). Major biologic functions influenced by miRNA action on gene expression are shown from Ingenuity Pathways Assessment (IPA)
analysis of MSCs from old and young donors. Involvement of biologic functions is determined from network and focus molecule association
with miRNA targets in IPA. (a) Downregulated miRNA in BMSCs from old donors, compared with young donors. (b) Upregulated miRNA in M-
MSCs from old donors, compared with young donors. (c) Downregulated miRNA in ASCs from old donors, compared with young donors. (d)
Upregulated miRNA in ASCs from old donors, compared with young donors. The yellow line represents P-value cutoff (P < 0.05).
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Page 10 of 18Figure 6 Top network analysis of focus molecules by Ingenuity Pathways Assessment (IPA) in bone marrow stem cells (BMSCs). (a, b)
Top two networks of focus molecules generated by IPA in direct or indirect regulation of gene expression by downregulated miRNA in BMSCs.
(c, d) Top two networks of focus molecules generated by IPA of directly and indirectly involved gene-expression regulation by upregulated
miRNA in BMSCs. Gray symbols, directly involved molecules, those inputted into IPA; white symbols, indirectly involved molecules, those
commonly associated with the genes/pathways demonstrated.
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Page 11 of 18analysis and the mRNA array also showed inhibition of
cell-cycle regulators such as cyclin-dependent kinases in
ASCs from old donors, compared with young donors
(Figure 8f through 8i).
Age-dependent expression of MAPK/ERK and NF-Bi n
MSCs
Further evaluation of protein expression showed signifi-
cant differences in detectable levels of screened
Figure 7 Top network analysis of focus molecules by Ingenuity Pathways Assessment (IPA) in adipose stem cells (ASCs). (a, b) Top two
networks of focus molecules generated by IPA in direct or indirect regulation of gene expression by downregulated miRNA in ASCs. (c, d) Top
two networks of focus molecules generated by IPA of directly and indirectly involved gene-expression regulation by upregulated miRNA in ASCs.
Gray symbols, directly involved molecules, those inputted into IPA; white symbols, indirectly involved molecules, those commonly associated
with the genes/pathways demonstrated.
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Page 12 of 18Figure 8 Evaluation of miRNA influence on mRNA levels in adipose stem cells (ASCs) from old and young donors. (a) The plot
demonstrates significant up- and downregulated mRNA in ACSs from old versus young donors. (b) Fold regulation of significant mRNA assessed
in ACSs from old versus young donors. (c) Heatmap shows old versus young donor mRNA expression levels; green represents downregulation of
mRNAs, and red represents upregulation of mRNAs. (d) The plot shows the top canonic pathways generated from Ingenuity Pathways
Assessment (IPA) analysis of mRNA differences in ACSs from old versus young donors. Yellow line, P-value cutoff (P < 0.05), and yellow dots, ratio
of projected involvement of targets to actual inputted involvement. Height of bars is determined by projected involvement of particular
pathway. (e) The plot shows top predicted biologic functions from the mRNA data inputted into IPA. Yellow line, P-value cutoff (P < 0.05). (f
through i) The top four networks involved in mRNA differences between ACSs from old versus young donors. White items, indirectly involved
molecules, those commonly associated with the genes/pathways demonstrated. Green items, downregulated molecules directly entered into IPA.
Red items, upregulated molecules based on fold change of mRNA.
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Page 13 of 18molecules, as predicted from the miRNA data. Immuno-
cytochemical localization of p65 and p50 subunits of
NF-B showed differential expression in cells from older
and younger donors (Figure 9a). In cells from younger
donors, NF-B appeared to localize predominantly
within the nucleus. In cells from older donors, however,
detectable NF-B was present in the nucleus, but dra-
matically elevated levels were observed in the cytoplasm.
The pattern of distribution was similar for both p65 and
p50 subunits of NF-B, but was much more pronounced
for p50. As assessed with Western blot, levels of phos-
phorylated inhibitory kappa B (p-IB) (P < 0.001), phos-
phorylated inhibitory kappa B kinase (p-IK) (P <
0.001), and inducible nitric oxide (iNOS) (P < 0.001)
were significantly decreased in ASCs from older donors,
compared with those from younger donors (Figure 9b,
d). Interestingly, this analysis showed that phosphory-
lated NF-B/p65 (p-NF-B) levels were significantly ele-
vated in ASCs from older donors as compared with
younger donors (P < 0.05). Furthermore, as predicted by
miRNA screening and mRNA data, Western blot analy-
s i ss h o w e dt h a tl e v e l so fp hosphorylated ERK1/2 (p-
ERK1/2) (P < 0.01), phosphorylated c-fos (p-c-fos) (P <
0. 01), phosphorylated c-jun (p-c-jun) (P < 0.001), and
phosphorylated JNK (p-JNK) (P < 0.001) were all signifi-
cantly decreased in ASC from older donors compared
with younger donors (Figure 9c, e).
Discussion
In the present study, the comprehensive miRNA profiles
of undifferentiated ASCs and BMSCs were analyzed to
identify age-related differences in constitutive potential
biologic functions at the mRNA and protein expression
levels. The results showed that in MSCs isolated from
two distinct tissues/organs, small subsets of miRNAs
display age-related differences in the regulation of gene
expression involving specific cellular and molecular
pathways of cell proliferation and inflammation, pre-
sumably as regimented markers of aging. Specifically,
significant age-related decreases were found in the
MAPK/ERK pathway and NF-B pathway expression.
O r i g i n a l l y ,i tw a st h o u g h tt h a tt h eh a l l m a r ko fM S C s
was their ability to differentiate into various end-cell
types for regenerative repair of damage due to injury
from disease processes [11,35,36]. Subsequently, many
reports suggested that the role of MSCs as treatment
modalities may occur through the expression of cyto-
kines and chemokines that promote angiogenesis or
squelch inflammatory responses, and adhesion mole-
cules that would subsequently induce endogenous repair
of injured cells and tissues [7]. In addition to these
mechanisms that MSCs use to ameliorate cellular
damage, their differentiation capabilities remain an
important defining characteristic. We confirmed that
ASCs from young donors, compared with those from
older donors, had significantly elevated potential to dif-
ferentiate toward osteogenic and adipogenic lineages.
Other studies found similar changes while investigating
aging of MSCs from humans, mice, rhesus macaques,
and cynomolgus monkeys [3,30,37,38]. Our flow-cyto-
metry results failed to detect changes in cell-surface
markers secondary to the aging process. Thus, despite
other age-related changes in MSCs, the cells can be
identified by using cell-surface markers frequently used
to distinguish MSCs from other cell types, regardless of
the age of the donor [27].
Analysis revealed that individual targets selected from
the IPA analysis followed the predicted pattern of
expression at the mRNA and protein levels. All evalu-
ated upregulated miRNA targets showed decreased
levels of both mRNA and functional protein, including
t h o s ei n v o l v e di nt h eM A P K / E R Ka n dN F - B pathways
and in cell-cycle control. This is in accordance with
recent results suggesting that although miRNAs pro-
mote both mRNA degradation and posttranslational
repression, they appear to act predominantly as regula-
tors at the mRNA level [19]. Furthermore, the current
findings suggest that the miRNA profile of MSCs can be
used to identify potential signaling mechanisms involved
in MSCs functions, and perhaps even provide another
way to classify MSCs function.
Several recent reports have demonstrated the function
of the let-7 family of miRNA and its role in MSCs, espe-
cially as markers and regulators of a differentiated state
[39]. The let-7 family was shown to repress cellular repli-
cation and inhibit self-renewal [40]. Our data showed
that let-7 family miRNA were significantly downregu-
lated in both ASCs and BMSCs from older donors.
Accordingly, it can be surmised that ASCs and BMSCs in
older donors may not be as efficient at self-renewal and
would have decreased overall proliferation, compared
with younger donors. Other reports determined that
human skeletal muscle cells from older donors demon-
strate reduced expression of let-7 and decreased mRNA
levels of cell-cycle regulators such as CDK6 [25]. Our
analysis of mRNA levels of cell-cycle regulatory mole-
cules found that multiple cyclin-dependent kinases were
downregulated, contributing to a reduction in cell prolif-
eration. The data also showed increased miRNA targeted
toward the Wnt/b-catenin-signaling pathway. Recent stu-
dies have shown that prolonged activation of Wnt signal-
ing promotes MSC proliferation and contributes to aging
[41]. Thus, our results demonstrate that miRNA inhibits
Wnt/b-catenin signaling to decrease cell proliferation in
aged MSCs, and potentially plays a role in retarding the
aging process in MSCs.
The miRNAs directed toward the MAPK/ERK system
were expressed at higher levels in cells from older
Pandey et al. Stem Cell Research & Therapy 2011, 2:49
http://stemcellres.com/content/2/6/49
Page 14 of 18Figure 9 Western blot analysis of differences in protein levels resulting from donor age and miRNA influences. (a) Immunocytochemical
localization of p65 and p50 subunits of NF-B in representative ASCs from old and young donors. Images are at ×20 magnification. Negative
controls are representative images per age group. Images are at ×5 magnification. (b) Representative Western blots of NF-B pathway elements
in ASCs from young (Y) and old (O) donors. (c) Representative Western blots of MAPK/ERK pathway elements in ASCs from young (Y) and old
(O) donors. (d) The quantitative fold change in expression of NF-B pathway proteins normalized to total actin levels. (e) The quantitative fold
change in MAPK signaling expression of proteins normalized to total actin levels. Bars, mean ± SEM of at least three Western blot quantifications.
*P < 0.05; **P < 0.01; ***P < 0.001).
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Page 15 of 18donors. Specifically, ERK1/2 and JNK gene expression
were involved as putative targets for miRNA-mediated
gene-expression control. The downregulation of mRNA
levels for c-fos and c-jun were confirmed by using real-
time PCR and, by Western blot, demonstrated decreased
protein levels of the MAPK pathway. Collectively p38,
p-ERK1/2, p-c-fos, p-c-jun, and p-JNK levels were all
significantly reduced in the ASCs of older donors as
compared with those of younger donors, with the exten-
sion to BMSCs due to a similar miRNA profile and IPA
analysis. Previous studies have indicated that BMSCs
from older donors have decreased proliferation potential
[2,42,43]. Additional reports have suggested that the
dynamics of the aging process of MSCs is a determinant
of cellular aging; however, the exact mechanism remains
unclear [10]. The identified differences in miRNA in
cells from older donors may represent the mechanism
by which MSCs, through control over the MAPK/ERK
signaling cascade, decrease cellular proliferation rates,
thereby contributing to reduced tissue renewal in aging.
Although many of the fine details of aging in humans
are yet to be elucidated, the interplay of aging and
inflammation has been intensively researched. Many
abnormalities in cellular processes have been found to
occur with aging, including the development of cancer
and type II diabetes mellitus [17,44]. At the center of
these disease processes lie the common denominators of
advanced age and inflammation. Interestingly, elevated
levels of activated NF-B were observed in older-donor
MSCs. Whereas regulatory and traditional components
of the NF-B pathway, including, among others, IB,
IK, iNOS, and IL-1a, were downregulated, other non-
traditionally associated molecules were upregulated,
including IL-4 receptor and myc oncogene. Tradition-
ally, protein factors responsive to NF-B transcriptional
regulation would further amplify NF-B expression,
which was not observed in the current study [45]. In
addition, the subcellular distribution of NF-B observed
in MSCs from older donors suggests the possibility of
an alternative role in MSCs aging. Aging and NF-B
activation may have more in common than was initially
postulated. Previous reports indicated that NF-Bc a n
function in resistance to apoptosis [46]. In addition, NF-
B was shown to repress apoptosis triggered by JNK
[47]. These observations, combined with our data show-
ing decreased levels of JNK, provide evidence that NF-
B may be central to a protective role in MSC aging.
Indeed, our data demonstrate that elevated levels of NF-
B regulated by miRNA activity may play a central role
in the onset and progression of the aging process in
MSCs.
The results also suggest that a delicate balance is
maintained as a result of increased NF-Be x p r e s s i o ni n
older MSCs. Typically, elevated levels of NF-Ba r e
linked with pathologic processes; in old cells, however,
elevated levels of NF-B could prevent apoptosis [45].
Prevention of apoptosis would be of substantial impor-
tance to MSCs, especially given their function for endo-
genous cellular repair. Most studies, however, have
demonstrated a potent anti-inflammatory role for MSCs
[7]. The paradigm shift occurs with the notion of how a
potently anti-inflammatory cell would maintain elevated
levels of NF-B. Our results demonstrated that although
NF-B levels are indeed elevated in older donors, pre-
sumably to prevent activation of apoptotic pathways,
other commonly associated molecules in the NF-B and
inflammatory cascade were downregulated. IPA analysis,
mRNA expression, and protein levels demonstrated that
molecules such as IL-1a,T N F - a,i N O S ,a n dI Kw e r e
significantly downregulated in ASCs from older donors.
In addition, JNK was also significantly downregulated in
older donors, giving support to the role of NF-Ba sa n
inhibitor of apoptosis. That IB levels decreased in the
older donor ASCs is indicative of prolonged NF-B
activity. Although the classic NF-B activity simulta-
neously causes de novo synthesis of IB, it appears that
NF-B levels that are elevated because of aging in MSCs
do not work through this mechanism. Intracellular loca-
lization of NF-B from the current study in cells from
younger donors appeared more predominant in the
nucleus, specifically in the nucleolus, whereas cells from
older donors demonstrated accumulation of NF-Bi n
the cytosol; these observation ss u g g e s tt h a ta l t h o u g hi t
was phosphorylated in both groups, NF-Bw a sf u n c -
tioning differently as a function of age. Alternatively,
relocalization of NF-B subunits to the cytosol may
indicate a lack of transcriptional activity, as further evi-
denced by decreased pro-inflammatory cytokines and
other molecules including IL-1a, IL-8, and iNOS mRNA
levels in cells from older donors compared with younger
donors. Further investigation of the role of elevated NF-
B levels is required to gain a full understanding of the
mechanisms at work in the MSC aging process.
Conclusions
In summary, miRNA profiling demonstrated that sub-
sets of miRNAs are biologically active in human MSCs,
with the profiles of miRNAs changing with aging in
both ASCs and BMSCs. Furthermore, miRNAs modu-
late and regulate gene expression related to a variety of
functions, particularly cellular proliferation and inflam-
mation, both of which play an integral role in the pro-
cess of aging. ASCs from older donors also exhibit
significantly elevated levels of NF-B, perhaps in
response to downregulation of the MAPK/ERK system
to prevent proliferation and inhibit apoptotic stimuli.
Interestingly, other molecules commonly associated with
NF-B were downregulated, leading to a unique and
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Page 16 of 18novel constellation of expression of the core inflamma-
tory molecules in a potently anti-inflammatory cell. The
current study presents, to our knowledge, the first
report that miRNAs have unique roles in the aging of
MSCs, maintaining their capacity to suppress inflamma-
tion and promote endogenous cellular repair while, per-
haps, allowing MSCs to escape the aging process.
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